SuspensionClinical Overview
Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Reconstitute dry syrup with boiled, cooled water up to the indicator mark. Shake thoroughly before each use. Must be administered with food or milk to optimize absorption. Store in refrigerator; discard after 14 days.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, nausea, vomiting, abdominal pain, headache, and diaper rash in infants. Rare/Severe: Pseudomembranous colitis, anaphylaxis, erythema multiforme, and thrombocytopenia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in cephalosporin allergy. Caution in penicillin-sensitive patients. Antacids and H2-blockers decrease oral absorption; administer at least 2-3 hours apart. Adjust dose in severe renal impairment.
Schedule H1 (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Cefpodoxime Proxetil Dispersible Tablets 100 mg
Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.
Cefpodoxime Tablets 200 mg
Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.
Cefpodoxime 200mg + Potassium Clavulanate 125mg Tablets
Cefpodoxime Proxetil and Potassium Clavulanate combines a third-generation cephalosporin with a beta-lactamase inhibitor. Clavulanic acid shields cefpodoxime from degradation by beta-lactamases produced by Staphylococcus aureus, H. influenzae, and enterobacteria. Indicated for community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute bacterial sinusitis, recurrent otitis media, and skin/soft tissue infections.
Cefpodoxime Proxetil Dispersible Tablets 50 mg
Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.